ID

15138

Descrizione

TGF-beta Resistant Cytotoxic T-lymphocytes in Treatment of EBV-positive Nasopharyngeal Carcinoma / RESIST-NPC; ODM derived from: https://clinicaltrials.gov/show/NCT02065362

collegamento

https://clinicaltrials.gov/show/NCT02065362

Keywords

versioni (1)
  1. 18/05/16 18/05/16 -
Caricato su

18 maggio 2016

DOI

Per favore, per richiedere un accesso.

Licenza

Creative Commons BY 4.0
Commenti del modello :

Puoi commentare il modello dati qui. Tramite i fumetti nei gruppi di articoli e articoli è possibile aggiungere commenti a quelli in modo specifico.

Torna ai commenti del modello
Commenti del gruppo di articoli per :

Commenti dell'articolo per :

Per scaricare i modelli di dati devi essere registrato. Per favore accesso o registrati GRATIS.

Eligibility EBV-positive Nasopharyngeal Carcinoma NCT02065362

Inglese

Eligibility EBV-positive Nasopharyngeal Carcinoma NCT02065362

1 moduli  
Inclusion Criteria
Descrizione

Inclusion Criteria

Alias
UMLS CUI
C1512693
the patient must meet the following eligibility inclusion criteria at the time of procurement:
Descrizione

Time Procurement

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0040223
UMLS CUI [1,2]
C1709695
nasopharyngeal carcinoma in first or subsequent relapse or with primary refractory disease
Descrizione

Nasopharyngeal cancer recurrent | Nasopharyngeal carcinoma Disease Primary Refractory

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0278952
UMLS CUI [2,1]
C2931822
UMLS CUI [2,2]
C0012634
UMLS CUI [2,3]
C2347678
ebv positive tumor
Descrizione

Malignant Neoplasms Epstein-Barr virus test positive

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0006826
UMLS CUI [1,2]
C1611703
informed consent explained to, understood by and signed by patient/guardian. patient/guardian given copy of informed consent
Descrizione

Informed Consent

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0021430
the patient must meet the following eligibility criteria to be included for treatment:
Descrizione

Inclusion criteria Therapeutic procedure

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C1512693
UMLS CUI [1,2]
C0087111
nasopharyngeal carcinoma in first or subsequent relapse or with primary refractory disease
Descrizione

Nasopharyngeal cancer recurrent | Nasopharyngeal carcinoma Disease Primary Refractory

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0278952
UMLS CUI [2,1]
C2931822
UMLS CUI [2,2]
C0012634
UMLS CUI [2,3]
C2347678
ebv positive tumor
Descrizione

Malignant Neoplasms Epstein-Barr virus test positive

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0006826
UMLS CUI [1,2]
C1611703
patients with life expectancy greater than or equal to 6 weeks
Descrizione

Life Expectancy

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0023671
bilirubin less than or equal to 3x upper limit of normal
Descrizione

Bilirubin, total measurement

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0201913
ast less than or equal to 5x upper limit of normal
Descrizione

Aspartate aminotransferase measurement

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0201899
hgb > 8.0g/dl (can be transfused)
Descrizione

Hemoglobin | Transfusion (procedure)

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0019046
UMLS CUI [2]
C1879316
creatinine less than or equal to 2x upper limit of normal for age
Descrizione

Creatinine measurement, serum | Upper Limit of Normal Age

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0201976
UMLS CUI [2,1]
C1519815
UMLS CUI [2,2]
C0001779
pulse oximetry of > 90% on room air
Descrizione

Pulse Oximetry on room air

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0034108
UMLS CUI [1,2]
C2709070
off investigational therapy for 4 weeks prior to study entry
Descrizione

Off Investigational Therapy

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C1518543
UMLS CUI [1,2]
C0949266
karnofsky or lansky score of greater than or equal to 50%
Descrizione

Karnofsky Performance Status | Lansky Play-Performance Status

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0206065
UMLS CUI [2]
C1522275
sexually active patients must be willing to utilize one of the more effective birth control methods during the study and for 6 months after the study is concluded. the male partner should use a condom.
Descrizione

Patients Sexually active | Contraceptive methods | Condoms, Male

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0030705
UMLS CUI [1,2]
C0241028
UMLS CUI [2]
C0700589
UMLS CUI [3]
C0009653
informed consent explained to, understood by and signed by patient/guardian. patient/guardian given copy of informed consent.
Descrizione

Informed Consent

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0021430
Exclusion Criteria
Descrizione

Exclusion Criteria

Alias
UMLS CUI
C0680251
at time of procurement:
Descrizione

Time Procurement

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0040223
UMLS CUI [1,2]
C1709695
•known hiv positivity
Descrizione

HIV Seropositivity

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0019699
at time of treatment:
Descrizione

Time Therapeutic procedure

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0040223
UMLS CUI [1,2]
C0087111
pregnant or lactating
Descrizione

Pregnancy | Breast Feeding

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
severe intercurrent infection
Descrizione

Intercurrent infection Severe

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0240021
UMLS CUI [1,2]
C0205082
Ritorna all'inizio della pagina

Similar models

Eligibility EBV-positive Nasopharyngeal Carcinoma NCT02065362

1 moduli
Name
genere
Description | Question | Decode (Coded Value)
Tipo di dati
Alias
Item Group
C1512693 (UMLS CUI)
Time Procurement
Item
the patient must meet the following eligibility inclusion criteria at the time of procurement:
boolean
C0040223 (UMLS CUI [1,1])
C1709695 (UMLS CUI [1,2])
Nasopharyngeal cancer recurrent | Nasopharyngeal carcinoma Disease Primary Refractory
Item
nasopharyngeal carcinoma in first or subsequent relapse or with primary refractory disease
boolean
C0278952 (UMLS CUI [1])
C2931822 (UMLS CUI [2,1])
C0012634 (UMLS CUI [2,2])
C2347678 (UMLS CUI [2,3])
Malignant Neoplasms Epstein-Barr virus test positive
Item
ebv positive tumor
boolean
C0006826 (UMLS CUI [1,1])
C1611703 (UMLS CUI [1,2])
Informed Consent
Item
informed consent explained to, understood by and signed by patient/guardian. patient/guardian given copy of informed consent
boolean
C0021430 (UMLS CUI [1])
Inclusion criteria Therapeutic procedure
Item
the patient must meet the following eligibility criteria to be included for treatment:
boolean
C1512693 (UMLS CUI [1,1])
C0087111 (UMLS CUI [1,2])
Nasopharyngeal cancer recurrent | Nasopharyngeal carcinoma Disease Primary Refractory
Item
nasopharyngeal carcinoma in first or subsequent relapse or with primary refractory disease
boolean
C0278952 (UMLS CUI [1])
C2931822 (UMLS CUI [2,1])
C0012634 (UMLS CUI [2,2])
C2347678 (UMLS CUI [2,3])
Malignant Neoplasms Epstein-Barr virus test positive
Item
ebv positive tumor
boolean
C0006826 (UMLS CUI [1,1])
C1611703 (UMLS CUI [1,2])
Life Expectancy
Item
patients with life expectancy greater than or equal to 6 weeks
boolean
C0023671 (UMLS CUI [1])
Bilirubin, total measurement
Item
bilirubin less than or equal to 3x upper limit of normal
boolean
C0201913 (UMLS CUI [1])
Aspartate aminotransferase measurement
Item
ast less than or equal to 5x upper limit of normal
boolean
C0201899 (UMLS CUI [1])
Hemoglobin | Transfusion (procedure)
Item
hgb > 8.0g/dl (can be transfused)
boolean
C0019046 (UMLS CUI [1])
C1879316 (UMLS CUI [2])
Creatinine measurement, serum | Upper Limit of Normal Age
Item
creatinine less than or equal to 2x upper limit of normal for age
boolean
C0201976 (UMLS CUI [1])
C1519815 (UMLS CUI [2,1])
C0001779 (UMLS CUI [2,2])
Pulse Oximetry on room air
Item
pulse oximetry of > 90% on room air
boolean
C0034108 (UMLS CUI [1,1])
C2709070 (UMLS CUI [1,2])
Off Investigational Therapy
Item
off investigational therapy for 4 weeks prior to study entry
boolean
C1518543 (UMLS CUI [1,1])
C0949266 (UMLS CUI [1,2])
Karnofsky Performance Status | Lansky Play-Performance Status
Item
karnofsky or lansky score of greater than or equal to 50%
boolean
C0206065 (UMLS CUI [1])
C1522275 (UMLS CUI [2])
Patients Sexually active | Contraceptive methods | Condoms, Male
Item
sexually active patients must be willing to utilize one of the more effective birth control methods during the study and for 6 months after the study is concluded. the male partner should use a condom.
boolean
C0030705 (UMLS CUI [1,1])
C0241028 (UMLS CUI [1,2])
C0700589 (UMLS CUI [2])
C0009653 (UMLS CUI [3])
Informed Consent
Item
informed consent explained to, understood by and signed by patient/guardian. patient/guardian given copy of informed consent.
boolean
C0021430 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Time Procurement
Item
at time of procurement:
boolean
C0040223 (UMLS CUI [1,1])
C1709695 (UMLS CUI [1,2])
HIV Seropositivity
Item
•known hiv positivity
boolean
C0019699 (UMLS CUI [1])
Time Therapeutic procedure
Item
at time of treatment:
boolean
C0040223 (UMLS CUI [1,1])
C0087111 (UMLS CUI [1,2])
Pregnancy | Breast Feeding
Item
pregnant or lactating
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
Intercurrent infection Severe
Item
severe intercurrent infection
boolean
C0240021 (UMLS CUI [1,1])
C0205082 (UMLS CUI [1,2])
Ritorna all'inizio della pagina 

Contatto

Si prega di utilizzare questo modulo per feedback, domande e suggerimenti per miglioramenti.

I campi contrassegnati da * sono obbligatori.

Aiuto

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial